Clinical Trial Update: Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions (PCI) (ISAR-REACT-3) [Phase 4]

View source ↗

Summary

Phase 4 trial ISAR-REACT-3 comparing unfractionated heparin with bivalirudin during percutaneous coronary intervention has completed, with results expected to i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Artery Disease

Drugs mentioned

• Bivalirudin (bivalirudin)
• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Coronary Disease, Angina Pectoris | Phase 4 | Status: COMPLETED